Navigation Links
Boston Scientific Announces Schedule for European Society of Cardiology Congress
Date:8/27/2009

ect," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding clinical trials, scientific activities, and product performance. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item IA- Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file thereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Boston Scientific Welcomes Results of Brain Aneurysm Clinical Trial
2. Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease
3. Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
4. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
5. Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientifics TAXUS(R) Liberte(R) Stent
6. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
7. Clinical Data Reinforce Safety and Efficacy of Boston Scientifics Two Drug- Eluting Stent Platforms
8. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
9. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
10. Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
11. Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientifics Next-Generation Taxus Liberte Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 2015  Cochlear Corporation Vice President of U.S. ... to join Valencia Technologies ( www.valenciatechnologies.com ) and ... , who is the CEO of Valencia.  Schloffman ... will be responsible for generating enthusiasm and support ... coin-sized neuromodulation device in the treatment of ...
(Date:3/30/2015)... -- New York College of Health Professions announces a valuable ... U.S. Patent #8,996,098 donated by its Chairman under the ... instrument that allows surgeons to view and compare what ... traditional format of a slide that is used during ... thus providing the surgeon real time analysis and information. ...
(Date:3/30/2015)... 30, 2015 Nutrastar International Inc. (OTCQB: NUIN) ... of premium branded consumer products, including commercially cultivated Cordyceps ... foods, today announced its results for the full year ... for the Full Year Ended December 31, 2014 ... as compared to $43.35 million in full year 2013. ...
Breaking Medicine Technology:Cochlear VP of U.S. Sales Jerry Schloffman Accepts Chief of Market Development Position at Valencia Technologies 2World Renowned Inventor Continues To Break Boundaries With Latest Patent 2World Renowned Inventor Continues To Break Boundaries With Latest Patent 3Nutrastar International, Inc. Announces Full Year 2014 Results 2Nutrastar International, Inc. Announces Full Year 2014 Results 3Nutrastar International, Inc. Announces Full Year 2014 Results 4Nutrastar International, Inc. Announces Full Year 2014 Results 5Nutrastar International, Inc. Announces Full Year 2014 Results 6Nutrastar International, Inc. Announces Full Year 2014 Results 7Nutrastar International, Inc. Announces Full Year 2014 Results 8Nutrastar International, Inc. Announces Full Year 2014 Results 9
... 5, 2011 Novavax, Inc. (NASDAQ: NVAX ... has been named by the editors of R&D ... great investigational drugs in development" today.  In its tenth ... Novavax,s virus-like-particle technology as a promising new approach to ...
... Systems, Inc. (NASDAQ: DCTH ), a development stage, ... today that the Company will meet this week with the ... to File letter that it received from the FDA on ... Application (NDA) for its proprietary chemosaturation system.  Delcath management will ...
Cached Medicine Technology:Novavax's VLP Influenza Vaccine Named One of Top 100 Drugs in Development Today 2Delcath to Update Investors on FDA Meeting 2Delcath to Update Investors on FDA Meeting 3
(Date:3/30/2015)... March 30, 2015 DMG Productions announces ... scheduled to broadcast on Monday, April 20, 2015 at ... Channel. , In this episode Innovations will explore ... to protect fragile, thinning skin on arms, hands, and ... will educate on how their products help reduce injuries, ...
(Date:3/30/2015)... March 30, 2015 The ... Orthopedic EHR, Orthopedic PACS) By Applications (Orthopedic ... By Mode of Delivery] – Global Forecast ... drivers, restraints and opportunities in North America, ... World (RoW). , Inquiry before Buying: ...
(Date:3/30/2015)... South Coast Surety is pleased to welcome Richard ... has been known to the management of South Coast ... University of Georgia, majoring in Banking and Finance. He enjoyed ... sales management of business equipment for a wide spectrum of ... was a senior officer with a National firm that does ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 Corra Group is ... accommodate the needs of every industry that requires this form ... compliance mandates or seek new ways to increase productivity and ... drug panels that will help detect substance abuse with a ... mandated drug tests,” said Corra Group Co-Founder, Gordon Basichis. ...
(Date:3/30/2015)... Mo. (PRWEB) March 30, 2015 ... a mobile library of medications used in behavioral ... for iPhone, iPad and Android—is a convenient, electronic ... annually since 1999. The useful resource provides up-to-date ... purpose, dosage and frequency, side effects, emergency conditions, ...
Breaking Medicine News(10 mins):Health News:New Episode of Innovations Airing Monday, April 20, 2015 Via Discovery Channel 2Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 2Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 3Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 4Health News:Richard Ford Joins South Coast Surety Contract Surety Team 2Health News:Corra Group Adds New Employment Screening Drug Test Solutions for Clients in Every Industry 2Health News:Corra Group Adds New Employment Screening Drug Test Solutions for Clients in Every Industry 3Health News:Popular Publication on Behavioral Health Medications Now An App 2
... , TUESDAY, Oct. 11 (HealthDay News) -- A small, preliminary study ... intestines -- a potential sign that the pills might reduce the ... be done, and the researchers aren,t yet recommending that people head ... meal times. "If you want to add ginger to part ...
... Goodwin HealthDay Reporter , TUESDAY, Oct. 11 (HealthDay ... raises the risk for both breast and ovarian cancer are ... new study indicates. Those other women include both women ... of breast and ovarian cancer, and women without ...
... A team of scientists led by a Penn State ... an alternative method of molecular depth profiling -- a ... such as human tissue, nanoparticles, and other substances. In ... modeling to show the effectiveness and limitations of the ...
... is exploring the ethical challenges that clinicians and ... in the United States. The project is supported by ... Program. Most of the estimated 11 million undocumented ... are ineligible for public insurance programs. They are prohibited ...
... intersection density and well-connected streets in towns and cities ... according to a Queen,s University study. "We,ve known ... a high density of intersections in a given areahelps ... and more efficient for them to walk to work ...
... TUESDAY, Oct. 11 (HealthDay News) -- Nearly 90 percent of ... well-being, according to a new national poll of 1,000 voters. ... also revealed that by having routine mammograms, women gain a ... that poll results show that nearly nine in 10 women ...
Cached Medicine News:Health News:Ginger Supplements Might Ease Inflammation Linked to Colon Cancer 2Health News:Mutant Gene That Ups Risk for Ovarian Cancer May Aid Survival 2Health News:Mutant Gene That Ups Risk for Ovarian Cancer May Aid Survival 3Health News:Mutant Gene That Ups Risk for Ovarian Cancer May Aid Survival 4Health News:Molecular depth profiling modeled using buckyballs and low-energy argon 2Health News:Molecular depth profiling modeled using buckyballs and low-energy argon 3Health News:New project examines medical safety net for undocumented patients 2Health News:Women Say Mammograms Give Them Sense of Control: Survey 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: